A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
Clinical trial NCT03764072 · COMPLETED
Trial details
- NCT number
- NCT03764072
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2019-01-17
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.